Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
British Journal of Cancer|June 20, 2013
Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancerC Blick, A Ramachandran, S Wigfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnairesG Velikova, E P Wright, A B Smith, et al.
British Journal of Cancer|February 27, 2015
Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAMR T Bryan, H L Regan, S J Pirrie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Feasibility and compliance of automated measurement of quality of life in oncology practiceE P Wright, P J Selby, M Crawford, et al.
Tubercle|March 1, 1989
Skin test responsiveness to a series of new tuberculins of children living in three Vietnamese citiesH M Ly, D D Trach, H T Long, et al.
Oncogene|February 16, 1999
Two novel regions of interstitial deletion on chromosome 8p in colorectal cancerS A Chughtai, M C Crundwell, N R Cruickshank, et al.
Prostate Cancer and Prostatic Diseases|February 16, 2005
Association between hormonal genetic polymorphisms and early-onset prostate cancerM S Forrest, S M Edwards, R Houlston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2014
Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancerM T W Teo, L Dyrskjøt, J Nsengimana, et al.
Cytogenetic and Genome Research|November 15, 2007
Disruption of the FA/BRCA pathway in bladder cancerK Neveling, R Kalb, A R Florl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2016
Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatmentD Pouessel, Y Neuzillet, L S Mertens, et al.
Pageof 13